ABRAXAS2
Basic information
Region (hg38): 10:124801819-124836667
Previous symbols: [ "KIAA0157", "FAM175B" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ABRAXAS2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 27 | 27 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 27 | 0 | 0 |
Variants in ABRAXAS2
This is a list of pathogenic ClinVar variants found in the ABRAXAS2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
10-124801890-A-C | not specified | Uncertain significance (May 23, 2023) | ||
10-124806899-C-G | not specified | Uncertain significance (Jan 29, 2025) | ||
10-124819397-G-A | not specified | Uncertain significance (Jan 29, 2024) | ||
10-124826622-C-T | not specified | Uncertain significance (Mar 28, 2023) | ||
10-124826629-C-T | not specified | Uncertain significance (Mar 01, 2025) | ||
10-124826640-A-T | not specified | Uncertain significance (Nov 06, 2023) | ||
10-124826647-A-T | not specified | Uncertain significance (Aug 01, 2024) | ||
10-124826676-A-T | not specified | Uncertain significance (Jan 10, 2023) | ||
10-124826688-G-A | not specified | Uncertain significance (Jul 19, 2022) | ||
10-124826691-G-A | not specified | Uncertain significance (Sep 16, 2021) | ||
10-124826718-A-G | not specified | Uncertain significance (Apr 23, 2024) | ||
10-124828778-G-T | not specified | Uncertain significance (Dec 27, 2023) | ||
10-124828779-C-A | not specified | Uncertain significance (Jun 29, 2022) | ||
10-124829436-G-A | not specified | Uncertain significance (Dec 04, 2023) | ||
10-124829460-C-G | not specified | Uncertain significance (Jan 23, 2025) | ||
10-124829470-A-C | not specified | Uncertain significance (Jun 06, 2023) | ||
10-124831352-G-A | not specified | Uncertain significance (Mar 21, 2023) | ||
10-124831405-A-T | not specified | Uncertain significance (Jul 12, 2023) | ||
10-124834523-G-C | not specified | Uncertain significance (Jan 08, 2024) | ||
10-124834561-A-G | not specified | Uncertain significance (Oct 11, 2024) | ||
10-124834574-C-T | not specified | Uncertain significance (Oct 26, 2021) | ||
10-124834636-C-T | not specified | Uncertain significance (Jan 18, 2023) | ||
10-124834681-T-G | not specified | Uncertain significance (Mar 22, 2023) | ||
10-124834699-G-A | not specified | Uncertain significance (Oct 20, 2021) | ||
10-124834727-A-C | not specified | Uncertain significance (Jan 04, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ABRAXAS2 | protein_coding | protein_coding | ENST00000298492 | 9 | 34886 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0202 | 0.979 | 125726 | 0 | 22 | 125748 | 0.0000875 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.11 | 189 | 237 | 0.796 | 0.0000127 | 2764 |
Missense in Polyphen | 31 | 56.317 | 0.55046 | 685 | ||
Synonymous | 0.561 | 81 | 87.7 | 0.924 | 0.00000520 | 759 |
Loss of Function | 2.97 | 7 | 22.0 | 0.318 | 0.00000116 | 256 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000936 | 0.0000904 |
Ashkenazi Jewish | 0.0000994 | 0.0000992 |
East Asian | 0.000164 | 0.000163 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000115 | 0.000114 |
Middle Eastern | 0.000164 | 0.000163 |
South Asian | 0.0000654 | 0.0000653 |
Other | 0.000165 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Component of the BRISC complex, a multiprotein complex that specifically cleaves 'Lys-63'-linked polyubiquitin, leaving the last ubiquitin chain attached to its substrates (PubMed:19214193, PubMed:20032457, PubMed:20656690, PubMed:24075985). May act as a central scaffold protein that assembles the various components of the BRISC complex and retains them in the cytoplasm (PubMed:20656690). Plays a role in regulating the onset of apoptosis via its role in modulating 'Lys- 63'-linked ubiquitination of target proteins (By similarity). Required for normal mitotic spindle assembly and microtubule attachment to kinetochores via its role in deubiquitinating NUMA1 (PubMed:26195665). Plays a role in interferon signaling via its role in the deubiquitination of the interferon receptor IFNAR1; deubiquitination increases IFNAR1 activities by enhancing its stability and cell surface expression (PubMed:24075985, PubMed:26344097). Down-regulates the response to bacterial lipopolysaccharide (LPS) via its role in IFNAR1 deubiquitination (PubMed:24075985). Required for normal induction of p53/TP53 in response to DNA damage (PubMed:25283148). Independent of the BRISC complex, promotes interaction between USP7 and p53/TP53, and thereby promotes deubiquitination of p53/TP53, preventing its degradation and resulting in increased p53/TP53-mediated transcription regulation and p53/TP53-dependent apoptosis in response to DNA damage (PubMed:25283148). {ECO:0000250|UniProtKB:Q3TCJ1, ECO:0000269|PubMed:19214193, ECO:0000269|PubMed:20032457, ECO:0000269|PubMed:20656690, ECO:0000269|PubMed:24075985, ECO:0000269|PubMed:25283148}.;
- Pathway
- Post-translational protein modification;Metabolism of proteins;Metalloprotease DUBs;Deubiquitination
(Consensus)
Recessive Scores
- pRec
- 0.109
Intolerance Scores
- loftool
- rvis_EVS
- -0.67
- rvis_percentile_EVS
- 15.62
Haploinsufficiency Scores
- pHI
- 0.655
- hipred
- Y
- hipred_score
- 0.670
- ghis
- 0.669
Essentials
- essential_gene_CRISPR
- essential_gene_CRISPR2
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- gene_indispensability_score
Mouse Genome Informatics
- Gene name
- Abraxas2
- Phenotype
- homeostasis/metabolism phenotype; immune system phenotype; hematopoietic system phenotype;
Gene ontology
- Biological process
- mitotic cell cycle;response to ischemia;chromosome segregation;attachment of spindle microtubules to kinetochore;protein deubiquitination;cell division;protein K63-linked deubiquitination;mitotic spindle assembly
- Cellular component
- cytoplasm;centrosome;cytosol;midbody;spindle pole centrosome;microtubule minus-end;BRISC complex
- Molecular function
- protein binding;microtubule binding;polyubiquitin modification-dependent protein binding